About Biometrica Health
Biometrica Health sells remote patient monitoring (RPM) to health plans, hospitals, and clinics. The platform is device-agnostic and supports FDA-approved sensors. It covers RPM, RTM, PCM, and TCM, and it also integrates behavioral health, all in one dashboard. The company runs the program for the customer: patient consent, device dropshipment, configurable threshold alerts, monthly check-in calls, and billing.
Biometrica Health is based in Minneapolis. Anthony P. C. Dann is the founder and chief executive officer. He studied entrepreneurship at the University of St. Thomas and co-founded a healthcare finance company that works with rural hospitals. He later led health technology projects with Mayo Clinic, Cardinal Health, and Optum. Scott Campbell is chief technology officer, and Nichole Klatt, PhD, is chief scientific officer. In May 2025 the company formed a partnership with BlueStar TeleHealth, a veteran-owned remote care provider.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | Oct 28, 2026 | $20,000of $2.0M target | 1 | $20,000 | SAFERule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Why Investors Backed Biometrica Health
Biometrica Health sells remote patient monitoring to health plans, hospitals, and clinics. The company is based in Minneapolis. Founder Anthony P. C. Dann leads it as chief executive officer. In May 2025 it partnered with BlueStar TeleHealth to add nurse-led patient support.
The problem it targets
Biometrica's case is that patients face their most vulnerable moments between appointments, when symptoms shift and conditions worsen. Problems in that gap, it argues, often go unnoticed until a patient lands in the emergency room instead of on a phone call. Dann's own history shaped the mission. A rare chronic illness and a life-saving surgery at Mayo Clinic led him to focus on wider access to quality care.
What the product does
The platform is sold as software, and the company earns revenue only when its partners do. Its argument is that both RPM and RTM are reimbursable across multiple CPT codes. It adds that health insurance normally pays for the data collection and for outreach from care coordinators. For health systems that review vendors for security, the platform is HIPAA-compliant, and BAAs are available.
Progress so far
On May 2, 2025, Biometrica announced a partnership with BlueStar TeleHealth. BlueStar adds nurse-led patient engagement and monitoring to Biometrica's platform. The combined offering lets providers start RPM without building their own clinical infrastructure. Early pilot deployments were under way then. The plan was to expand into family medicine practices, critical access hospitals, and rural clinics in the following months. The company has also been accepted into UC Berkeley's Health Engine Cohort IX.
We wrote this summary from public statements by Biometrica Health and its investors. It is not investment advice.
Leadership Team
Executive officers and directors listed on Biometrica Health's Form D filed Oct 28, 2026.
